Andere Sprachen Inozyme Pharma, Inc.

Aktien

A2P86D

US45790W1080

INZY

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 07.05.2024			% 5 Tage	% 1. Jan.
4,6 ^USD	-5,74 %		+4,31 %	+7,98 %

07.05.	Inozyme Pharma, Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
08.04.	Transcript : Inozyme Pharma, Inc. - Special Call

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Inozyme Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07.05.
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights	07.05.
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	06.05.
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03.05.
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency	08.04.
Inozyme Pharma, Inc. Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with Abcc6 Deficiency and ENPP1 Deficiency	08.04.
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	06.04.
Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference	02.04.
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024	26.03.
Inozyme Pharma, Inc. to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency	26.03.
Inozyme Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12.03.
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights	12.03.
Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference	26.02.
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	06.02.
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05.12.
Inozyme Pharma to Participate in Upcoming Investor Conferences	09.11.
Inozyme Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07.11.
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights	07.11.
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03.11.
Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023	26.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Inozyme Pharma, Inc.

Aktien

A2P86D

US45790W1080

INZY

Andere Sprachen

Filter